← Open Payments lookup

FREDDY ALI: Open Payments

NPI 1851504922 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$66,722 in 137 payments from 9 companies in 2025. Trend: 2023 $11,472 · 2024 $27,451 · 2025 $66,722

Speaker / faculty: $31,920Consulting: $25,105Travel & lodging: $6,423Food & beverage: $3,275
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.60$34,069
E.R. Squibb & Sons, L.L.C.28$15,318
Teva Pharmaceuticals USA, Inc.6$9,306
Alkermes, Inc.17$7,563
ABBVIE INC.11$159
Otsuka America Pharmaceutical, Inc.8$154
Janssen Pharmaceuticals, Inc5$121
Almatica Pharma LLC1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: INGREZZA, LYBALVI, COBENFY, UZEDY, VRAYLAR, REXULTI, INVEGA SUSTENNA, ARISTADA.

Industry payments across PA — which companies pay providers there.